別品名 |
4-[4-(4-fluorophenyl)-5-pyridin-4-yl-1,3-dihydroimidazol-2-ylidene]cyclohexa-2,5-dien-1-one
|
純度 |
>=98%
|
分子量 |
331.3
|
CAS RN® |
152121-30-7
|
構造 |
C20H14FN3O
|
使用目的 |
SB 202190 is a selective and potent p38 MAP kinases inhibitor, binding to its ATP pocket. It has negligible inhibiting properties on other MAP kinases such as ERKs and JNKs. SB 202190 is reported to be used to induce cardiomyocyte differentiation from human embryonic stem cells and increase neural stem cell self-renewal.
|
|
メーカー |
品番 |
包装 |
BGM
|
1523072-10MG
|
10 MG
|
※表示価格について
当社在庫 |
なし
|
納期目安 |
2週間程度
|
保存温度 |
-20℃
|
|